XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Earnings (Deficit)
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2021   74,142,183      
Beginning balance at Dec. 31, 2021 $ 1,322,377 $ 741 $ 1,074,286 $ 309,430 $ (62,080)
Stock-based compensation plans          
Stock Issued During Period, Value, Restricted Stock Award, Gross 0 $ 1 (1)    
Grant of restricted stock (in shares)   110,400      
Stock Issued During Period, Value, New Issues (1,350) $ 1 (1,351)    
Issuance of common shares, net of withholdings (in shares)   85,343      
Forfeited restricted stock (in shares)   (700)      
Retained earnings     (39,559) 20,871  
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition 1,654   1,654    
Total comprehensive income $ 50,047     49,796 251
Ending balance at Mar. 31, 2022         (61,829)
Beginning balance (in shares) at Dec. 31, 2022 72,327,758 72,327,758      
Beginning balance at Dec. 31, 2022 $ 1,412,506 $ 723 986,303 528,882 (103,402)
Stock-based compensation plans          
Stock Issued During Period, Value, New Issues (1,553) $ 2 (1,555)    
Issuance of common shares, net of withholdings (in shares)   124,152      
Forfeited restricted stock (in shares)   (300)      
Stock repurchased during period, value   $ (10) (22,127)    
Stock repurchased during period (in shares)   1,000,000      
Purchase of common stock (22,137)        
Retained earnings (18,688)        
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition 1,405   1,405    
Total comprehensive income $ 23,846     20,141 3,705
Ending balance (in shares) at Mar. 31, 2023 71,451,610 71,451,610      
Ending balance at Mar. 31, 2023 $ 1,414,067 $ 715 $ 964,026 $ 549,023 $ (99,697)